M&A Deal Summary

Tempest Therapeutics Acquires Millendo Therapeutics

On March 29, 2021, Tempest Therapeutics acquired life science company Millendo Therapeutics

Acquisition Highlights
  • This is Tempest Therapeutics’ 1st transaction in the Life Science sector.
  • This is Tempest Therapeutics’ 1st transaction in the United States.
  • This is Tempest Therapeutics’ 1st transaction in Michigan.

M&A Deal Summary
Date 2021-03-29
Target Millendo Therapeutics
Sector Life Science
Buyer(s) Tempest Therapeutics
Deal Type Merger
Advisor(s) Leerink Partners (Financial)
Wilmer Cutler Pickering Hale and Dorr (Legal)

Target

Millendo Therapeutics

Ann Arbor, Michigan, United States
Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Millendo Therapeutics creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. Millendo Therapeutics is based in Ann Arbor, Michigan.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Tempest Therapeutics

Brisbane, California, United States
Category Company
Founded 2011
Sector Life Science
Employees17
Revenue 29M USD (2023)
DESCRIPTION

Tempest Therapeutics is a clinical-stage oncology company advancing small molecules that combine both targeted and immune-mediated mechanisms with the potential to treat a wide range of tumors. Tempest Therapeutics is developing an inhibitor of TREX-1, a double-stranded DNA exonuclease that is designed to control activation of the cGAS/STING pathway, which is an innate immune response pathway that induces the production of IFN-?, a cytokine that is well-established to trigger the development of anti-tumor immunity. Tempest Therapeutics was founded in 2011 and is based in Brisbane, California.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Merger) 1 of 1
State (Michigan) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1
Mergr

Product

Company

Legal